ZYBT

Zhengye Biotechnology-A Cross-source read
Health CareCUSIP G989MS101

Among active 13F managers last quarter, 1 added and 2 reduced; the largest holder to move was XTX Topco Ltd (−26%). No recent Form 4 insider filings for ZYBT.

Tracked 13F holders
8
13F value (tracked)
$83K
Smart-money readBearish
Net sellingNet buying
Funds · active managers, latest 13F
1 adding · 2 trimming
Insiders · Form 4 open-market, 180d
0 buying · 0 selling
US House · STOCK Act, 180d
0 buying · 0 selling

Funds lean out and no leg opposes.

Who owns ZYBT?

8 tracked 13F filers · ranked by shares held

8 tracked 13F filers disclose a position in ZYBT as of the latest SEC 13F filings, a combined $83K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1XTX Topco Ltd44K
$41K
−26%
Reduced · −15K sh
Q1 2026
2Geode Capital Management, LLC29K
$20K
Held
Q2 2026
3Winton Group Ltd13K
$9K
−62%
Reduced · −21K sh
Q2 2026
4UBS Group AG8K
$8K
−12%
Reduced · −1K sh
Q1 2026
5Tower Research Capital LLC (TRC)5K
$5K
+123%
Added · +3K sh
Q1 2026
6Royal Bank Of Canada1K
$1K
+221%
Added · +847 sh
Q1 2026
7Morgan Stanley261
$244
−84%
Reduced · −1K sh
Q1 2026
8Caitong International Asset Management Co., Ltd1
$1
Held
Q2 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is ZYBT being bought or sold by institutions?

Last quarter, 1 fund added to an existing position in ZYBT, while 2 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Added
1
added to an existing position
Reduced
2
reduced, still holding
Biggest moves · ranked by size of the change, positions above a floor

Insider activity (Form 4)

No open-market insider transactions on file yet. Grants, gifts, and exercises live on the full insider page.

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
24
Insiders
Form 4 open-market
00$0
US House
STOCK Act trades
00$0

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Recent filings

0 most recent

No filings captured for this ticker in the live stream yet.

Keep exploring

Connected entities for ZYBT

Browse more

Build

Ask your agent what changed in ZYBT

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/ZYBT/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for ZYBT.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + the live filing stream, joined for ZYBT. Filings are public domain, sourced to SEC EDGAR.